ClinicalTrials.Veeva
Menu

Find clinical trials for Adenocarcinoma in Montréal, QC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Pancreatic Cancer
Colorectal Cancer
Stomach Cancer
Prostatic Cancer
Esophageal Cancer

Adenocarcinoma trials near Montréal, QC, CAN:

Adjuvant Androgen Suppression Plus Radiation Therapy for High-Risk Localized Adenocarcinoma Prostate

To evaluate the efficacy of LHRH agonist with adjuvant pelvic radiation therapy in post radical prostatectomy patients with high risk pathological fe...

Active, not recruiting
Adenocarcinoma of the Prostate
Radiation: Androgen suppression plus radiation therapy

Phase 2

Sir Mortimer B. Davis - Jewish General Hospital

Montreal, Quebec, Canada and 1 other location

for front line treatment of locally-advanced pancreatic adenocarcinoma.The device is an experimental, portable, battery operated device for ...

Active, not recruiting
Pancreas Adenocarcinoma
Drug: Gemcitabine
Drug: nab paclitaxel

Phase 3

NovoCure
NovoCure

Montréal, Quebec, Canada and 197 other locations

mFOLFIRINOX alone in participants with resected pancreatic ductal adenocarcinoma (PDAC) who have not received prior systemic anti-cancer tre...

Enrolling
Adenocarcinoma, Pancreatic Ductal
Drug: mFOLFIRINOX
Drug: Autogene cevumeran

Phase 2

Genentech
Genentech

Montreal, Quebec, Canada and 38 other locations

The standard or usual treatment for this disease consists of two chemotherapy drugs gemcitabine and nab-paclitaxel given together.

Active, not recruiting
Pancreatic Adenocarcinoma
Drug: Gemcitabine
Drug: Tremelimumab

Phase 2

Canadian Cancer Trials Group

Montreal, Quebec, Canada and 26 other locations

and safety of AZD0901 compared to Investigator's choice of therapy as 2L+ treatment for participants with advanced or metastatic gastric or GEJ adenocarcinoma...

Enrolling
Gastroesophageal Junction Cancer
Gastric Cancer
Drug: AZD0901
Drug: Docetaxel

Phase 3

AstraZeneca
AstraZeneca

Montreal, Quebec, Canada and 157 other locations

unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma. Why is this study being done? SPOTLIGHT is a new clinical st...

Active, not recruiting
Metastatic Gastric Adenocarcinoma or Cancer
Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer
Drug: fluorouracil
Drug: zolbetuximab

Phase 3

Astellas
Astellas

Montreal, Quebec, Canada and 219 other locations

This research is designed to determine if experimental treatment with Antibody-drug conjugate, AZD5335, alone, or in combination with anti-cancer age...

Enrolling
Lung Adenocarcinoma
Ovarian Cancer
Drug: AZD5305
Drug: AZD5335

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Montreal, Quebec, Canada and 38 other locations

untreated adults with gastric and gastroesophageal junction (GEJ) adenocarcinoma.The primary study hypotheses are that:* Neoadjuvant and adj...

Active, not recruiting
Gastroesophageal Junction Cancer
Gastric Cancer
Drug: Capecitabine
Drug: Oxaliplatin

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Montreal, Quebec, Canada and 170 other locations

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for advanced pancreatic cancer.

Enrolling
Pancreatic Adenocarcinoma
Metastatic Pancreatic Cancer
Device: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
Alpha Tau Medical

Montréal, Quebec, Canada and 1 other location

GEJ adenocarcinoma in adult participants.The primary hypotheses of this study are that pembrolizumab plus chemotherapy is superior to place...

Active, not recruiting
Stomach Neoplasms
Drug: capecitabine
Drug: Cisplatin

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Montreal, Quebec, Canada and 214 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems